Skip to main content
. 2017 Apr 6;7:46025. doi: 10.1038/srep46025

Table 4. Antibiotic resistance of G+ C bacteria (strains, n).

Antibiotics Staphylococcus aureus (n = 30) P Coagulase negative staphylococcus (n = 131) P Enterococcus (n = 76)
Community-acquired (n = 9) Nosocomial (n = 21) Community-acquired (n = 56) Nosocomial (n = 75) Nosocomial (n = 76)
MRSA (n = 6) MSSA (n = 3) MRSA(n = 6) MSSA (n = 15) MRSCON (n = 40) MSSCON (n = 16) MRSCON (n = 61) MSSCON (n = 14) Faecalis (n = 52) Faecium (n = 18)
SBL 6 3 6 15 40 9 61 7 0.56 22 5
Penicillin G 6 3 6 15 40 9 61 7 0.56 48 5
Ceftriaxone 6 0 6 0 0.05 40 0 61 0 0.18  
Cefoxitin 6 0 6 0 0.05 40 0 61 0 0.18  
Amikacin 3 0 4 2 0.79 17 0 5 0 <0.01  
Levofloxacin 4 2 6 2 0.15 11 2 34 0 <0.01 39 5
SMZ 2 0 2 1 0.59 20 6 35 1 0.86  
Clindamycin 4 3 2 5 <0.01 18 5 36 1 0.35  
Erythromycin 3 2 2 10 0.94 25 11 54 7 0.03 41 11
Vancomycin 0 0 0 1 0.51 0 0 0 0 0 0
Linezolid 0 0 0 0 1 0 0 0 0.24 1 3
Teicoplanin 0 0 0 0 0 0 2 0 0.22 1 0
Tetracycline 3 0 4 2 0.79 10 4 15 3 0.90 48 11